OppenheimerFunds’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,233,132
Closed -$91.2M 1860
2018
Q3
$91.2M Sell
4,233,132
-1,321
-0% -$30.7K 0.11% 216
2018
Q2
$103M Buy
4,234,453
+4,945
+0.1% +$101K 0.12% 187
2018
Q1
$72.3M Buy
4,229,508
+566,300
+15% +$11.1M 0.09% 243
2017
Q4
$69.4M Buy
+3,663,208
New +$55.1M 0.08% 247
2017
Q3
Sell
-521,869
Closed -$17.3M 1871
2017
Q2
$17.3M Sell
521,869
-142,701
-21% -$4.42M 0.02% 597
2017
Q1
$21.3M Sell
664,570
-899,405
-58% -$30.7M 0.03% 561
2016
Q4
$56.7M Sell
1,563,975
-328,400
-17% -$13.1M 0.07% 283
2016
Q3
$87.1M Sell
1,892,375
-143,185
-7% -$7.47M 0.11% 220
2016
Q2
$102M Sell
2,035,560
-116,605
-5% -$6.21M 0.13% 187
2016
Q1
$115M Sell
2,152,165
-532,760
-20% -$31.3M 0.15% 163
2015
Q4
$176M Sell
2,684,925
-245,716
-8% -$15.2M 0.22% 112
2015
Q3
$165M Buy
2,930,641
+678,370
+30% +$44M 0.22% 118
2015
Q2
$133M Sell
2,252,271
-50,384
-2% -$3.11M 0.15% 170
2015
Q1
$143M Buy
2,302,655
+1,159,690
+101% +$67.4M 0.16% 167
2014
Q4
$65.7M Sell
1,142,965
-316,524
-22% -$17.6M 0.07% 291
2014
Q3
$78.4M Sell
1,459,489
-232,791
-14% -$12.3M 0.09% 243
2014
Q2
$88.7M Sell
1,692,280
-22,755
-1% -$1.16M 0.1% 226
2014
Q1
$90.6M Sell
1,715,035
-143,816
-8% -$6.65M 0.11% 220
2013
Q4
$74.5M Sell
1,858,851
-410,359
-18% -$16.2M 0.09% 247
2013
Q3
$85.7M Buy
2,269,210
+188,980
+9% +$7.37M 0.11% 225
2013
Q2
$81.5M Buy
+2,080,230
New +$81M 0.12% 221

Other funds holding TEVA